Javascript must be enabled to continue!
FERTILITY PRESERVATION: Exploring the complexities of posthumous reproduction in fertility preservation for oncology patients with poor prognosis
View through CrossRef
The field of fertility preservation (FP) for oncology patients has evolved significantly in recent years, offering new possibilities for individuals with life-threatening illnesses. We commend Jones
et al.
for their comprehensive ethical review of offering FP to patients with poor prognoses, acknowledging the potential benefits that it may bring. ‘Poor prognosis’ in this context implies a high likelihood of death due to cancer progression. We highlight the importance of considering posthumous reproduction, involving the use of cryopreserved gametes or embryos to conceive a child after one or both partners have passed away, a topic briefly mentioned by Jones
et al.
Posthumous reproduction raises complex ethical, logistical, and legal questions. Distinctions between cryopreserved sperm and oocytes are discussed, with each scenario presenting unique challenges. The article also examines the complexities faced by same-sex couples in posthumous reproduction, addressing issues related to donor selection, legal parentage, and rights. Legal and regulatory aspects play a crucial role, including obtaining clear and legally valid consent, defining parental rights, navigating surrogacy laws, and addressing inheritance and estate planning. Ethical dilemmas require healthcare professionals to ensure informed decision-making, consider psychological impacts, and offer information on alternative family-building options.
Lay summary
Cancer treatments can have a negative impact on a person’s ability to have children, and some cancer survivors may end up being unable to conceive. Fortunately, there are currently available technologies that can help preserve fertility for these patients. These options include freezing eggs or sperm before starting cancer treatment. For patients who have been diagnosed with cancer and have a poor prognosis, meaning they are not likely to survive their illness, it is crucial to think about what happens to their frozen eggs and sperm in case of their death. This process of conceiving a child after someone's passing is known as ‘posthumous reproduction’. In our article, we explore the ethical, legal, and logistical challenges that the surviving partners of patients who may not live long enough to have a child with their frozen eggs or sperm might face. We pay particular attention to same-sex couples because their surviving partners often encounter more obstacles. In some countries, posthumous reproduction in these circumstances is even prohibited by law. There is a significant variation in the regulations related to posthumous reproduction, both between different countries and within individual countries. These differences need to be carefully considered when healthcare professionals counsel patients and their family members.
Title: FERTILITY PRESERVATION: Exploring the complexities of posthumous reproduction in fertility preservation for oncology patients with poor prognosis
Description:
The field of fertility preservation (FP) for oncology patients has evolved significantly in recent years, offering new possibilities for individuals with life-threatening illnesses.
We commend Jones
et al.
for their comprehensive ethical review of offering FP to patients with poor prognoses, acknowledging the potential benefits that it may bring.
‘Poor prognosis’ in this context implies a high likelihood of death due to cancer progression.
We highlight the importance of considering posthumous reproduction, involving the use of cryopreserved gametes or embryos to conceive a child after one or both partners have passed away, a topic briefly mentioned by Jones
et al.
Posthumous reproduction raises complex ethical, logistical, and legal questions.
Distinctions between cryopreserved sperm and oocytes are discussed, with each scenario presenting unique challenges.
The article also examines the complexities faced by same-sex couples in posthumous reproduction, addressing issues related to donor selection, legal parentage, and rights.
Legal and regulatory aspects play a crucial role, including obtaining clear and legally valid consent, defining parental rights, navigating surrogacy laws, and addressing inheritance and estate planning.
Ethical dilemmas require healthcare professionals to ensure informed decision-making, consider psychological impacts, and offer information on alternative family-building options.
Lay summary
Cancer treatments can have a negative impact on a person’s ability to have children, and some cancer survivors may end up being unable to conceive.
Fortunately, there are currently available technologies that can help preserve fertility for these patients.
These options include freezing eggs or sperm before starting cancer treatment.
For patients who have been diagnosed with cancer and have a poor prognosis, meaning they are not likely to survive their illness, it is crucial to think about what happens to their frozen eggs and sperm in case of their death.
This process of conceiving a child after someone's passing is known as ‘posthumous reproduction’.
In our article, we explore the ethical, legal, and logistical challenges that the surviving partners of patients who may not live long enough to have a child with their frozen eggs or sperm might face.
We pay particular attention to same-sex couples because their surviving partners often encounter more obstacles.
In some countries, posthumous reproduction in these circumstances is even prohibited by law.
There is a significant variation in the regulations related to posthumous reproduction, both between different countries and within individual countries.
These differences need to be carefully considered when healthcare professionals counsel patients and their family members.
Related Results
Accuracy of medical oncology prognosis for patients with metastatic cancer evaluated for enrollment onto an ongoing randomized clinical trial.
Accuracy of medical oncology prognosis for patients with metastatic cancer evaluated for enrollment onto an ongoing randomized clinical trial.
12063 Background: For patients with metastatic cancer, a key aspect of interdisciplinary care has involved the overall prognosis provided by Medical Oncology, which often dictates...
Functional and aesthetic comparison of lower lip split incisions and modification of McGregor incision. (Preprint)
Functional and aesthetic comparison of lower lip split incisions and modification of McGregor incision. (Preprint)
BACKGROUND
The open mouth provided the basis for various surgical approaches to tumours of the oral cavity(1). If this access is inadequate it is generally ...
Fertility preservation and fertility treatment in transgender adolescents and adults in a Swedish region, 2013–2018
Fertility preservation and fertility treatment in transgender adolescents and adults in a Swedish region, 2013–2018
Abstract
STUDY QUESTION
In a transgender population referred for fertility consultation, which factors influence the decision to...
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Navigating fertility dilemmas across the lifespan in girls with Turner syndrome—a scoping review
Navigating fertility dilemmas across the lifespan in girls with Turner syndrome—a scoping review
Abstract
BACKGROUND
Girls with Turner syndrome (TS) lack a partial or complete sex chromosome, which causes an accelerated decli...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Improving Access for Patients Undergoing Gonadotoxic Therapy: Creation of a Formal Fertility Preservation Program [25A]
Improving Access for Patients Undergoing Gonadotoxic Therapy: Creation of a Formal Fertility Preservation Program [25A]
INTRODUCTION:
Prior to 2016, patients undergoing gonadotoxic therapies were not routinely directed towards educational resources regarding fertility preservation option...
Residential and wealth-related disparities of high fertility preferences in Ethiopia: A decomposition analysis
Residential and wealth-related disparities of high fertility preferences in Ethiopia: A decomposition analysis
Background
Fertility preference significantly influences contraceptive uptake and impacts population growth, especially in low and middle-income countries. In the previous pieces o...

